VN February 2026

Vetnews | Februarie 2026 22 « BACK TO CONTENTS Live-attenuated foot-and-mouth disease virus vaccine engineered by codon deoptimization induces a strong protective immune response in cattle Sarah E. Attreed, Christina Silva, Monica Rodriguez-Calzada, Ryan D. Heimroth, Michael Oldakowski, Carolina Stenfeldt, Paul Azzinaro, Edward Spinard, Aishwarya Mogulothu, Steffen Mueller, Bruce Taillon, Jonathan Arzt, Elizabeth Rieder, Teresa de los Santos, Fayna Díaz-San Segundo & Gisselle N. Medina. We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note that there may be errors present which affect the content, and all legal disclaimers apply. If this paper is published under a Transparent Peer Review model, then Peer Review reports will be published with the final article. 1. U.S. Department of Agriculture, Agricultural Research Service, Plum Island Animal Disease Centre, Greenport, New York, United States of America 2. U.S. Department of Agriculture, Agricultural Research Service, National Bio- and Agro-Defence Facility, Manhattan, Kansas, United States of America 3. PIADC Research Participation Program, Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, Tennessee, United States of America 4. Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA 5. Department of Pathobiology and Veterinary Science, University of Connecticut, Mansfield, CT, USA 6. Codagenix, Farmingdale, New York, United States of America Current Affiliations • #aU.S. Department of Agriculture, Animal Plant and Health Inspection Services, National Veterinary Services Laboratories, Ames, Iowa, United States of America • #bOffice of Biodefense, Research, Resources and Translational Research, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America *Correspondence: Teresa.delossantos@usda.gov (T.D.L.S); fayna.diazsansegundo@nih.gov (F.D.-S.S.); gisselle.medina@usda.gov (G.M.) ABSTRACT Foot-and-mouth disease (FMD) is a fast-spreading, economically devastating veterinary viral disease. While inactivated vaccines have contributed to FMD control worldwide, recent outbreaks in Europe and Asia highlight the need for new control strategies. Live-attenuated virus vaccines (LAV) provide strong and long-lasting protection. We previously demonstrated that deoptimization of various viral coding regions results in attenuated foot-and-mouth disease virus (FMDV). Here, an FMDV A24Cruzeiro LAV with codon-deoptimized P2/P3 regions (A24-P2/P3Deopt) and markers differentiating infected from vaccinated animals (DIVA) was tested for safety/efficacy in cattle. Animals inoculated intradermal-lingually (IDL) with 106 or 107 pfu of A24-P2/P3Deopt for safety testing exhibited no clinical signs, viremia or viral shedding for 28 days post inoculation (DPI). To assess efficacy, cattle were subcutaneously inoculated either once with 105 pfu or twice (0- and 14-dpi) with 104, 105 or 106 pfu A24P2/P3Deopt. No animal developed signs of disease post-inoculation. All vaccinated animals developed strong neutralising antibody responses that were protective against challenge with WT FMDV A24 prime-boost groups. Moreover, vaccinated sera showed strong cross-reactivity against several A strains and serotype Asia1. Our work demonstrates that codon deoptimization is a viable technology to derive novel LAV candidates that are safe, immunogenic and efficacious against FMD in cattle. INTRODUCTION Foot-and-mouth disease (FMD) is a highly transmissible disease of even-toed ungulates, characterised by the development of vesicles on the mouths, feet and teats of affected individuals 1. FMD is known to affect over 70 wild and domestic species such as swine, cattle, sheep, goats and cervids 1. Given the host range of the disease, it is of great agricultural interest around the world, particularly in pig and ruminant agriculture. FMD is one of 26 multi-species reportable terrestrial diseases for the World Organisation for Animal Health (WOAH) 2. While mortality from FMD is low, the disease is of great economic importance as it is highly transmissible and there are restrictions on the movement and export of animal products from FMD-endemic countries. Therefore, maintenance of FMD-free status is a valuable economic asset for all countries worldwide. Foot-and-mouth disease virus (FMDV) is the causative agent of FMD and is a member of the Picornaviridae family along with enteroviruses such as Poliovirus. FMDV is a single-stranded, positive-sense RNA virus of approximately 8.5 kb composed of a single open reading frame (ORF), flanked by 5’ and 3’ untranslated regions (UTRs). The ORF is divided into four main regions: Leader proteinase (Lpro), P1, P2 and P3. Upon translation, the immature polyprotein is processed by 2A (a non-canonical protease that cleaves immature proteins by translational ribosome skipping) as well as the classical viral proteinases Lpro and 3Cpro into structural proteins—1A (VP4), 1B (VP2), 1C (VP3), and 1D (VP1)—as well as nonstructural (NS) proteins—2A, 2B, 2C, 3A, three distinct 3B genome-linked proteins (Vpg) 3, 3Cpro and RNA-dependent RNA polymerase 3Dpol. Current control measures in FMD-free countries include culling of infected and contact animals, movement restrictions of infected and contact animals and sometimes prophylactic ring vaccination with an adjuvanted inactivated vaccine 4, which, when combined with Montanide ESSAI IMS D 12802 VG PR aqueous adjuvant, can confer protective immunity within 4 days 5. Another candidate vaccine under conditional license in the US employs a replication-defective adenovirus 5 (Ad5) encoding only the P1 capsid, 2B and 3C protease domains 6. While the Ad5-FMD vaccine has been shown to confer immunity in approximately 7 days, similar to the commercially available inactivated vaccine, neither confers long-lasting immunity, which is often a function of strong T cell engagement during the post-vaccination period. To address the desire for more durable immunity as well as to possibly broaden the cross-neutralisation potential of the vaccines available for FMD, other methods of vaccine preparation are being employed. One of the most successful methods for vaccination against viral infections

RkJQdWJsaXNoZXIy OTc5MDU=